首页 > 市场调查报告书 > 食物/饮料

机能性食品

市场调查报告书

商品编码

1455746

全球减肥药市场 - 2023-2030

Global Diet Pills Market - 2023-2030

出版日期: 2024年03月26日 | 出版商:

DataM Intelligence | 英文 240 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球减肥药市场规模达33.4亿美元，预计2030年将达到56.5亿美元，2023-2030年预测期间CAGR为6.8%。

由于肥胖病例的增加，减肥药在市场上越来越受欢迎。超重和肥胖已成为成人和儿童的主要问题。根据《2023 年世界卫生统计》，预计到 2022 年，约有 3,700 万名五岁以下儿童患有肥胖症。随着儿童长大成人，儿童肥胖可能导致过早死亡和残疾。

人们健康意识的提高正在增加减肥的方法。根据《2023 年减肥统计》，约 40% 的人透过避免节食来减肥，近 30% 的人愿意阻止体重增加。减肥药在体重管理方面的便利性和有效性正在推动其在全球范围内的流行。

FDA 和其他组织对减肥药物的批准增加，积极推动了市场成长。例如，2021年，Weglovy品牌的索马鲁肽被FDA批准用于治疗成人超重和肥胖。北美地区的大力促销活动和新产品开发使其在全球市场的份额增加至1/3。

动力学

肥胖症盛行率不断上升

久坐生活方式的人被迫食用高糖和高脂肪的加工产品。由于日程繁忙，人们开始选择即食食品。高热量食物的消费增加和体力活动的减少导致肥胖等生活方式疾病的高发生率。此外，工作人群面临的各种状况，如压力和睡眠不足，也是导致肥胖的一些原因。

世界肥胖联合会2023预测，肥胖病例正在迅速增加，未来12年内全球一半以上的人口可能面临肥胖和超重问题。人们日益增强的健康意识正在推动可减轻体重和提供健康身体的产品市场的发展。减肥药对减肥的帮助可以成为市场更大的动力。

增加使用膳食补充剂来减肥

据 NIH 称，大约 15% 的美国成年人登记使用减肥膳食补充剂。据报道，其中女性使用药物的比例为 21%，而男性使用比例为 10%。各种形式的膳食补充剂（例如片剂、胶囊和粉末形式）的出现推动了其扩张机会。

膳食补充剂具有抑制食慾和增加新陈代谢的功能，透过燃烧脂肪对体重管理产生正面影响。越来越多的新产品推出市场，越来越受到消费者的关注。例如，2023年7月，减肥补充剂品牌Hydroxycut推出了新产品线Hardcore。此系列产品包括胶囊、软糖和饮料棒。

对副作用的担忧

减肥药可能有助于减肥，但可能会引起一些副作用。胃肠道问题是减肥药最常见的副作用，包括腹泻、胀气和胃痛。研究也发现，减肥药会导致肝臟和肾臟出现严重的健康问题。此类药物可能会增加甲状腺癌的风险，并可能降低血糖水平。此类减肥药危及生命的副作用使人们担心使用它们，阻碍了市场规模的扩大。

减肥药在最终产品之前需要经过多次试验，这可能需要更多的投资。此外，组织和政府对减肥药审批的严格规定也会阻碍市场业务。出于安全考虑，美国FDA限製或禁止了多种减肥药。例如，2023年8月，FDA发布公告，声称不要购买Alfia减肥药，因为其含有西布曲明物质，该物质已于2010年从市场下架。

Diet pills are gaining immense popularity in the market due to increasing obesity cases. Overweight and obesity have become a major problem in adults and children. According to World Health Statistics 2023, it is identified that there were around 37.0 million children under five years of age suffering from obesity in 2022. Childhood obesity can lead to premature death and disability as children grow into adults.

Increased health consciousness among people is increasing the approaches for weight loss. According to Weight-Loss Statistics 2023, about 40% of people are avoiding diet to lose weight, and nearly 30% of people are willing to prevent their weight gain. The convenience and effectiveness of diet pills in weight management are driving thier popularity globally.

Increased approvals of weight loss drugs by the FDA and other organizations positively drive market growth. For instance, in 2021, Semaglutide, from the Weglovy brand, was approved by the FDA to treat overweight and obesity in adults. The high promotional activities and new product developments in North America increase its share to 1/3rd of global market.

Dynamics

Growing Prevalence of Obesity

People with sedentary lifestyles are forced to eat processed products high in sugars and fats. With hectic schedules, people are choosing ready-to-eat food products. The increased consumption of food with higher calories and reduced physical activity leads to a high prevalence of lifestyle diseases such as obesity. In addition, the working population are experiencing various condition, such as stress and poor sleep, which are some of the causes of obesity.

The World Obesity Federation 2023 predicts that obesity cases are rapidly increasing, and more than half of the worldwide population might deal with obesity and overweight in the coming 12 years. The rising health consciousness among people is driving the market for products that can reduce their weight and provide a healthy body. The help of diet pills in reducing weight can be a greater driving force for the market.

Increased Use of Dietary Supplements for Weight Loss

According to NIH, approximately 15% of U.S. adults are registered to use weight-loss dietary supplements. Among these, women are reported to use 21 % of pills, while men are subjected to the 10% use. The availability of dietary supplements in various forms, such as tablets, capsules, and powder forms, drives its expansion opportunities.

The functionality of dietary supplements in suppressing the appetite and increasing metabolism positively affects weight management by burning fat. The increased number of new products launched into the market is gaining consumer's attention. For instance, in July 2023, Hydroxycut, a weight-loss supplements brand, introduced its new product line, Hardcore. This line range products comprises capsules, gummies and drink sticks.

Concerns About Side Effects

The diet pills may help weight loss but can cause several side effects. Gastrointestinal problems are diet pills' most common side effects, including diarrhoea, gas and stomach ache. It is also observed that weight loss pills can lead to severe health issues in the liver and kidneys. Such pills may increase thyroidal cancer risk and may lower blood sugar levels. Life-threatening side effects of such diet pills are making people worried about using them, hindering the market size expansion.

The diet pills need to go through several trials before finalizing the product, which may need more investments in them. In addition, the strict regulations about diet pill approvals from organizations and governments can hamper the market business. Considering the safety concerns, U.S. FDA restricted or banned several weight loss pills. For instance, in August 2023, the FDA released a public notification claiming not to purchase Alfia weight loss pills due to its sibutramine substance, that is removed from the market in 2010.

Segment Analysis

The global diet pills market is segmented based on source, type, form, age group, function, usage, distribution channel, application, end-user and region.

Increased Health Awareness

The global diet pills market is segmented based on weight loss and body-shaping usage. This market's weight loss pills segment is gaining immense popularity among teenagers and adults, leading to a larger share of this segment. The rising health concerns of being overweight such as high blood pressure, type 2 diabetes and heart problems, encourage people to take action to lose weight, driving the segment growth.

According to Weight-Loss Statistics 2023, about 40% of people are avoiding diet to lose weight, and just under 30% of people are willing to prevent their weight gain. The rising number of people willing to lose weight and use diet pills to reduce their weight positively impacts the segment's growth. In addition, the new product launches from the key market players in the weight loss category increase the segment demand.

Geographical Penetration

Increased Obesity Cases

North America held the largest share of the global diet pills market. The increased self-awareness about weight management is the key factor driving the market in this region. The increased employment-population ratio of this region has a greater influence on their food patterns. The hectic lifestyles of people increased their consumption of processed food products.

The unhealthy lifestyle of people of this region has led to increased obesity. According to the Centers for Disease Control and Prevention 2023, United States has around 41.9% of adults and 19.7 % of children suffering from obesity. The increased prevalence of obesity and the increase in people's awareness about weight loss drive this region's diet pills market growth.

According to UNC Gillings School of Global Public Health 2021, about 34% of Americans willing to lose weight have used weight loss supplements. The stronger influence of social media on people's lifestyles and more importance for body shape maintenance may positively affect the diet pills market as people are willing to adopt diet pills to lose weight.

Competitive Landscape

The major global players in the market include Nirvasa, Applied Nutrition, Lovate Health Sciences Inc, Chong's Health Care, Healthviv, MuscleTech, Nov- Nordisk A/S, Vivus LLC, Now Foods and Herbalife.

COVID-19 Impact Analysis

The outbreak of COVID-19 had a mixed impact on the global diet pills market. The strict government regulations restricted people to their houses. The increased time for cooking in the pandemic period increased people's food intake. There is increased consumption of processed food products due to their convenience. The high calories and fats of such food products increase the prevalence of obesity.

According to NIH, there is an increased prevalence of obesity among 2 to 20-year age groups during lockdowns. People were not allowed outside their houses, decreasing their physical activity. The shutdown of gyms and exercise centers made it difficult for people to lose weight, giving rise to diet pills. The high food consumption and decreased physical activity, increased the demand for diet pills as people started their weight management.

Further, the pandemic gave rise to e-commerce sector activities. Most people started using online platforms for their necessary purchases. The accessibility and popularity of the e-commerce sector and the wide availability of diet pill products in online platforms increased the market demand. The halted supply chain activities and distribution channel processes created a little disturbance in the diet pills market.

Russia- Ukraine War Impact

The Russia-Ukraine war had a negative impact on many industrial sectors, including food support and services sector. The labor shortage and a lack of resources for the production and distribution of diet pills badly impacted the market. The supply chain and distribution channels were negatively affected, decreasing market growth.

War decreased people's affordability to high-priced products like diet pills. The war created import and export trade disruptions, resulting in product haltation in reach to target customers. The high taxes and increased prices of commodities created economic disturbances. The trade The political and economic uncertainty created due to the war had a negative impact on the diet pills market.

By Source

Leaves
Barks
Fruits and Vegetables
Roots

By Type

Prescription
Over the Counter Drugs
Herbal Supplements
Others

By Form

Tablets
Capsules
Powder
Liquid
Softgels

By Age Group

Children
Adolescents
Adults
Over Adults

By Function

Medicinal
Aroma
Others

By Usage

Weight Loss
Body Shaping

By Distribution Channels

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies

By Application

Appetite Suppression
Metabolism Raising Pills
Fat Blocking
Others

By End-User

Hospitals
Weight Loss Centers
Home Use

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In July 2023, a Denmark-based global healthcare company, Novo Nordisk, introduced its weight loss drug Wegovy in Germany.
In May 2023, Noom, a U.S.-based weight loss startup, unveiled a program prescribing new weight-reducing drugs like Wegovy.
In November 2022, a U.S.-based Audax Private Equity, announced the acquisition, of Medi-Weightloss, Inc., a weight-loss and diet pills offering company. This acquisition helps the Medi-Weightloss company to expand its business range.

Why Purchase the Report?

To visualize the global diet pills market segmentation based on source, type, form, age group, function, usage, distribution channel, application, end-user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of diet pills market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global diet pills market report would provide approximately 109 tables, 121 figures and 240 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Source
3.2.Snippet by Type
3.3.Snippet by Form
3.4.Snippet by Age Group
3.5.Snippet by Function
3.6.Snippet by Usage
3.7.Snippet by Distribution Channels
3.8.Snippet by Application
3.9.Snippet by End-User
3.10.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Growing Prevalence of Obesity
  - 4.1.1.2.Increased Use of Dietary Supplements for Weight Loss
- 4.1.2.Restraints
  - 4.1.2.1.Concerns About Side Effects
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Source

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2.Market Attractiveness Index, By Source
7.2.Leaves
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Barks
7.4.Fruits and Vegetables
7.5.Roots

8.By Type

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2.Market Attractiveness Index, By Type
8.2.Prescription
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Over the Counter Drugs
8.4.Herbal Supplements

9.By Form

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.1.2.Market Attractiveness Index, By Form
9.2.Tablets
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Capsules
9.4.Powder
9.5.Liquid
9.6.Softgels

10.By Age Group

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.1.2.Market Attractiveness Index, By Age Group
10.2.Children
- 10.2.1.Introduction
- 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3.Adolescents
10.4.Adults
10.5.Over Adults

11.By Function

11.1.Introduction
- 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 11.1.2.Market Attractiveness Index, By Function
11.2.Medicinal
- 11.2.1.Introduction
- 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3.Aroma
11.4.Others

12.By Usage

12.1.Introduction
- 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 12.1.2.Market Attractiveness Index, By Usage
12.2.Weight Loss
- 12.2.1.Introduction
- 12.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3.Body Shaping

13.By Distribution Channels

13.1.Introduction
- 13.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channels
- 13.1.2.Market Attractiveness Index, By Distribution Channels
13.2.Hospital Pharmacies
- 13.2.1.Introduction
- 13.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
13.3.Drug Stores & Retail Pharmacies
13.4.Online Pharmacies

14.By Application

14.1.1.Introduction
14.1.2.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
14.1.3.Market Attractiveness Index, By Application

14.2.Appetite Suppression
- 14.2.1.Introduction
- 14.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
14.3.Metabolism Raising Pills
14.4.Fat Blocking
14.5.Others

15.By End-User

15.1.Introduction
- 15.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 15.1.2.Market Attractiveness Index, By End-User
15.2.Hospitals
- 15.2.1.Introduction
- 15.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
15.3.Weight Loss Centers
15.4.Home Use

16.By Region

16.1.Introduction
- 16.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 16.1.2.Market Attractiveness Index, By Region
16.2.North America
- 16.2.1.Introduction
- 16.2.2.Key Region-Specific Dynamics
- 16.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.2.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.2.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.2.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 16.2.12.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 16.2.12.1.U.S.
  - 16.2.12.2.Canada
  - 16.2.12.3.Mexico
16.3.Europe
- 16.3.1.Introduction
- 16.3.2.Key Region-Specific Dynamics
- 16.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.3.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.3.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.3.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 16.3.12.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 16.3.12.1.Germany
  - 16.3.12.2.U.K.
  - 16.3.12.3.France
  - 16.3.12.4.Italy
  - 16.3.12.5.Spain
  - 16.3.12.6.Rest of Europe
16.4.South America
- 16.4.1.Introduction
- 16.4.2.Key Region-Specific Dynamics
- 16.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.4.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.4.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.4.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 16.4.12.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 16.4.12.1.Brazil
  - 16.4.12.2.Argentina
  - 16.4.12.3.Rest of South America
16.5.Asia-Pacific
- 16.5.1.Introduction
- 16.5.2.Key Region-Specific Dynamics
- 16.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.5.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.5.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.5.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 16.5.12.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 16.5.12.1.China
  - 16.5.12.2.India
  - 16.5.12.3.Japan
  - 16.5.12.4.Australia
  - 16.5.12.5.Rest of Asia-Pacific
16.6.Middle East and Africa
- 16.6.1.Introduction
- 16.6.2.Key Region-Specific Dynamics
- 16.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 16.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 16.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 16.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 16.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
- 16.6.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
- 16.6.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 16.6.10.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 16.6.11.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

17.Competitive Landscape

17.1.Competitive Scenario
17.2.Market Positioning/Share Analysis
17.3.Mergers and Acquisitions Analysis

18.Competitive Landscape

18.1.Competitive Scenario
18.2.Market Positioning/Share Analysis
18.3.Mergers and Acquisitions Analysis

19.Company Profiles

19.1.Nirvasa
- 19.1.1.Company Overview
- 19.1.2.Product Portfolio and Description
- 19.1.3.Financial Overview
- 19.1.4.Key Developments
19.2.Applied Nutrition
19.3.Lovate Health Sciences Inc
19.4.Chong's Health Care
19.5.Healthviv
19.6.MuscleTech
19.7.Nov- Nordisk A/S
19.8.Vivus LLC
19.9.Now Foods
19.10.Herbal

LIST NOT EXHAUSTIVE

20.Appendix

20.1.About Us and Services
20.2.Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球减肥药市场 - 2023-2030

Global Diet Pills Market - 2023-2030

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：COVID-19 分析

第 7 章：按来源

第 8 章：按类型

第 9 章：按形式

第 10 章：依年龄组

第 11 章：按功能

第 12 章：按用途

第 13 章：按分销管道

第 14 章：按应用

第 15 章：最终用户

第 16 章：按地区

第17章：竞争格局

第18章：竞争格局

第 19 章：公司简介

第 20 章：附录